1. Home
  2. BLFS vs CET Comparison

BLFS vs CET Comparison

Compare BLFS & CET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLFS
  • CET
  • Stock Information
  • Founded
  • BLFS 1987
  • CET 1929
  • Country
  • BLFS United States
  • CET United States
  • Employees
  • BLFS N/A
  • CET N/A
  • Industry
  • BLFS Medical/Dental Instruments
  • CET Finance/Investors Services
  • Sector
  • BLFS Health Care
  • CET Finance
  • Exchange
  • BLFS Nasdaq
  • CET Nasdaq
  • Market Cap
  • BLFS 1.1B
  • CET 1.2B
  • IPO Year
  • BLFS 1989
  • CET N/A
  • Fundamental
  • Price
  • BLFS $21.38
  • CET $46.75
  • Analyst Decision
  • BLFS Strong Buy
  • CET
  • Analyst Count
  • BLFS 7
  • CET 0
  • Target Price
  • BLFS $30.57
  • CET N/A
  • AVG Volume (30 Days)
  • BLFS 602.5K
  • CET 20.4K
  • Earning Date
  • BLFS 05-08-2025
  • CET 01-01-0001
  • Dividend Yield
  • BLFS N/A
  • CET 4.80%
  • EPS Growth
  • BLFS N/A
  • CET 26.33
  • EPS
  • BLFS N/A
  • CET 9.95
  • Revenue
  • BLFS $87,762,000.00
  • CET $23,698,535.00
  • Revenue This Year
  • BLFS $21.21
  • CET N/A
  • Revenue Next Year
  • BLFS $17.58
  • CET N/A
  • P/E Ratio
  • BLFS N/A
  • CET $4.69
  • Revenue Growth
  • BLFS 34.80
  • CET 11.75
  • 52 Week Low
  • BLFS $18.70
  • CET $40.24
  • 52 Week High
  • BLFS $29.55
  • CET $49.51
  • Technical
  • Relative Strength Index (RSI)
  • BLFS 43.02
  • CET 62.16
  • Support Level
  • BLFS $21.48
  • CET $45.89
  • Resistance Level
  • BLFS $22.72
  • CET $46.90
  • Average True Range (ATR)
  • BLFS 1.02
  • CET 0.57
  • MACD
  • BLFS -0.12
  • CET -0.05
  • Stochastic Oscillator
  • BLFS 31.11
  • CET 56.36

About BLFS BioLife Solutions Inc.

BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.

About CET Central Securities Corporation

Central Securities Corp is a non-diversified closed-end management investment company. Its investment objective is long-term growth of capital. The company invests in common stocks, bonds, convertible bonds, preferred stocks, convertible preferred stocks, warrants, options real estate, or short-term obligations of governments, banks, and corporations.

Share on Social Networks: